| Prenatal Testing Firm Cradle Genomics Debuts With $17M, Illumina Ties | Sarah de Crescenzo | 07/16/19 | San Diego |
| West Coast Biotech Roundup: Juno, UCSD v. USC, Natera, LSDF & More | Alex Lash | 07/06/15 | Seattle |
| Natera Secures $180,000,000 New Funding | VentureDeal | 07/02/15 | San Francisco |
| Prenatal Tester Natera Now Shooting for $175M IPO | Alex Lash | 07/01/15 | San Francisco |
| Prenatal Screener Natera Grabs $55M, Considers Cancer Test | David Holley | 04/06/15 | San Francisco |
| Natera Secures $55,500,000 New Round | VentureDeal | 04/06/15 | San Francisco |
| Ariosa Takes Pre-Natal Genetic Test to Wall Street, Eyes $69M IPO | Ben Fidler | 03/25/14 | San Francisco |
| Miscarriage Mysteries Create New Market for Natera | Bernadette Tansey | 02/12/14 | San Francisco |
| Cellscape Hunts for Fetal Cells in Mom, Pushing Diagnostic Frontier | Luke Timmerman | 08/21/13 | San Francisco |
| Natera Grabs $55M For Push into Prenatal Genetic Screening | Luke Timmerman | 05/01/13 | San Francisco |
| Natera Secures $54,600,000 Series E Financing | VentureDeal | 05/01/13 | San Francisco |
| Six Reasons Why Illumina Has Nothing to Fear from Thermo/Life | Luke Timmerman | 04/29/13 | National |
| San Diego Life Sciences Roundup: IPOs, ResMed, Ventrix, CovX, & More | Bruce V. Bigelow | 02/21/13 | San Diego |
| Natera Joins Quest in Four-Way Battle for Prenatal Genetic Tests | Luke Timmerman | 02/20/13 | San Francisco |
| Illumina Acquires Verinata Health, Prenatal Testmaker, For $350M | Luke Timmerman | 01/07/13 | San Diego |
| Who Should Life Science Pros Follow on Twitter? | Luke Timmerman | 09/24/12 | National |
| Biotech Begins to Come of Age on Twitter | Luke Timmerman | 09/17/12 | National |
| Verinata’s Big Day Arrives, With Prenatal Down Syndrome Test Debut | Luke Timmerman | 02/29/12 | San Francisco |
| Gene Security Network, Now Natera, Adds $20M For Prenatal Tests | Luke Timmerman | 01/06/12 | San Francisco |
| Natera Lands $20,000,000 New Financing Round | VentureDeal | 01/06/12 | San Francisco |
